GeneReach Biotechnology Corp. (TPEX:4171)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
21.95
+0.45 (2.09%)
Jan 22, 2026, 12:59 PM CST
-20.18%
Market Cap1.24B
Revenue (ttm)215.32M
Net Income (ttm)-148.46M
Shares Out57.70M
EPS (ttm)-2.60
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,693,232
Average Volume229,233
Open23.65
Previous Close21.50
Day's Range21.50 - 23.65
52-Week Range15.40 - 29.40
Beta0.50
RSI66.22
Earnings DateMar 26, 2026

About GeneReach Biotechnology

GeneReach Biotechnology Corp. develops, manufactures, and markets products for applied nucleic acid detection technology in Taiwan. The company offers various equipment, such as POCKIT Central Nucleic Acid Analyzer, POCKIT Micro Series, taco mini Automatic Nucleic Acid Extraction System, taco Prep Homogenization System, and cubee Mini-Centrifuge; reagents and consumables, including Human IVD Assays, iiPCR Specific Reagents, research reagents and consumables, as well as taco Nucleic Acid Extraction Reagents, IQ REAL Quantitative System, and IQ20... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2004
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 4171
Full Company Profile

Financial Performance

In 2024, GeneReach Biotechnology's revenue was 206.49 million, a decrease of -8.41% compared to the previous year's 225.46 million. Losses were -118.73 million, -28.59% less than in 2023.

Financial Statements